Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients’ outcome?

Detalles Bibliográficos
Autores principales: Bouchla, Anthi, Papageorgiou, Sotirios G., Symeonidis, Argyris, Sakellari, Ioanna, Zikos, Panagiotis, Thomopoulos, Thomas P., Hatzimichael, Eleftheria, Galanopoulos, Athanasios, Vyniou, Nora-Athina, Kotsianidis, Ioannis, Pappa, Vasiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681887/
https://www.ncbi.nlm.nih.gov/pubmed/37816955
http://dx.doi.org/10.1038/s41375-023-02051-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681887/
https://www.ncbi.nlm.nih.gov/pubmed/37816955
http://dx.doi.org/10.1038/s41375-023-02051-3

Ejemplares similares